|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| Current assets | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Accounts receivable, net of $15 and $16 in allowances, respectively | ||||||||||||||||
| Other current assets | ||||||||||||||||
| Total current assets | ||||||||||||||||
| Property and equipment, net of $412 and $381 in accumulated depreciation, respectively | ||||||||||||||||
| Operating lease assets | ||||||||||||||||
| Goodwill | ||||||||||||||||
| Identifiable intangible assets, net of $184 and $164 in accumulated amortization, respectively | ||||||||||||||||
| Other long-term assets | ||||||||||||||||
| Total long-term assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||
| Current liabilities | ||||||||||||||||
| Accounts payable | ||||||||||||||||
| Accrued expenses | ||||||||||||||||
| Short-term debt and current maturities of long-term debt | ||||||||||||||||
| Short-term operating lease liabilities | ||||||||||||||||
| Other current liabilities | ||||||||||||||||
| Total current liabilities | ||||||||||||||||
| Long-term debt and obligations under finance leases | ||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||
| Other long-term liabilities | ||||||||||||||||
| Total long-term liabilities | ||||||||||||||||
| Equity | ||||||||||||||||
| Preferred stock, $0.01 par value; 10,000 shares authorized; 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||
| Common stock, $0.01 par value; 300,000 shares authorized; 164,920 and 164,160 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Accumulated deficit | ||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||
| Total equity | ||||||||||||||||
| Total liabilities and equity | ||||||||||||||||
| Common stock, shares outstanding (in shares) | ||||||||||||||||
| Common stock, shares issued (in shares) | ||||||||||||||||
Loading...
